ENTRY       D00781                      Drug
NAME        Entacapone (JP18/USP/INN);
            Comtan (TN)
PRODUCT     COMTAN (Almatica Pharma LLC)
            ENTACAPONE (Wockhardt USA LLC.)
  GENERIC   ENTACAPONE (Ajanta Pharma USA)
            ENTACAPONE (Alembic Pharmaceuticals Limited)
            ENTACAPONE (Alembic Pharmaceuticals)
            ENTACAPONE (American Health Packaging)
            ENTACAPONE (Aphena Pharma Solutions - Tennessee)
            ENTACAPONE (Aurobindo Pharma Limited)
            ENTACAPONE (AvPAK)
            ENTACAPONE (Lannett Company)
            ENTACAPONE (Macleods Pharmaceuticals Limited)
            ENTACAPONE (NCS HealthCare of KY)
            ENTACAPONE (Sandoz)
            ENTACAPONE (Sun Pharmaceutical Industries)
FORMULA     C14H15N3O5
EXACT_MASS  305.1012
MOL_WEIGHT  305.286
CLASS       Neuropsychiatric agent
             DG01497  Catechol O-methyltransferase inhibitor
             DG01967  Antiparkinson agent
              DG02909  COMT inhibitor
            Metabolizing enzyme inhibitor
             DG01643  CYP2C9 inhibitor
REMARK      Same as: C07943
            Therapeutic category: 1169
            ATC code: N04BX02
            Product: D00781<JP/US>
            Product (mixture): D10293<JP/US>
EFFICACY    Antiparkinsonian, Antidyskinetic, COMT inhibitor
  DISEASE   Parkinson disease [DS:H00057]
COMMENT     Nitrocactechols
TARGET      COMT [HSA:1312] [KO:K00545]
  PATHWAY   hsa04728(1312)  Dopaminergic synapse
INTERACTION CYP inhibition: CYP2C9 [HSA:1559]
            Enzyme inhibition: COMT [HSA:1312]
STR_MAP     map07057  Antiparkinsonian agents
            map07216  Catecholamine transferase inhibitors
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N04 ANTI-PARKINSON DRUGS
               N04B DOPAMINERGIC AGENTS
                N04BX Other dopaminergic agents
                 N04BX02 Entacapone
                  D00781  Entacapone (JP18/USP/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antiparkinson Agents
              Antiparkinson Agents, Other
               Entacapone
                D00781  Entacapone (JP18/USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              11  Agents affecting central nervous system
               116  Antiparkinsonian agents
                1169  Others
                 D00781  Entacapone (JP18/USP/INN)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01497  Catechol O-methyltransferase inhibitor
               D00781  Entacapone
              DG01967  Antiparkinson agent
               DG02909  COMT inhibitor
                D00781  Entacapone
             Metabolizing enzyme inhibitor
              DG01643  CYP2C9 inhibitor
               D00781  Entacapone
            Drug classes [BR:br08332]
             Neuropsychiatric agent
              DG01967  Antiparkinson agent
               D00781  Entacapone
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Transferases (EC2)
               Methyltransferases
                COMT
                 D00781  Entacapone (JP18/USP/INN) &lt;JP/US&gt;
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00781  Entacapone
              D00781  Entacapone tablets
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D00781
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D00781
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D00781
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D00781
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D00781
DBLINKS     CAS: 130929-57-6
            PubChem: 7847846
            ChEBI: 4798
            PDB-CCD: PD9
            LigandBox: D00781
            NIKKAJI: J506.416C
ATOM        22
            1   C8y C    31.3202  -14.7134
            2   C8x C    32.5093  -14.0267
            3   C2b C    30.1199  -14.0267
            4   C8x C    31.3146  -16.1044
            5   C8y C    33.7153  -14.7134
            6   C2c C    28.9193  -14.7077
            7   C8y C    32.5093  -16.8027
            8   C8y C    33.7153  -16.1044
            9   N2b N    34.9158  -14.0267 #+
            10  C5a C    27.7247  -14.0208
            11  C3b C    28.9193  -16.0870
            12  O1a O    32.4565  -18.1878
            13  O1a O    34.9216  -16.7969
            14  O3a O    34.9216  -12.6357
            15  O3a O    36.1162  -14.7077 #-
            16  N1c N    26.5244  -14.7019
            17  O5a O    27.7305  -12.6300
            18  N3a N    28.8957  -17.8178
            19  C1b C    25.3297  -14.0093
            20  C1b C    26.5244  -16.0813
            21  C1a C    24.1293  -14.6961
            22  C1a C    25.3297  -16.7795
BOND        22
            1     1   2 2
            2     1   3 1
            3     1   4 1
            4     2   5 1
            5     3   6 2
            6     4   7 2
            7     5   8 2
            8     5   9 1
            9     6  10 1
            10    6  11 1
            11    7  12 1
            12    8  13 1
            13    9  14 2
            14    9  15 1
            15   10  16 1
            16   10  17 2
            17   11  18 3
            18   16  19 1
            19   16  20 1
            20   19  21 1
            21   20  22 1
            22    7   8 1
///
